 |
| Photo from Department of Health |
The Hong Kong government has been gearing up for the coming Flu season, buying 1.3 million doses of vaccines for its Seasonal Influenza Vaccination Programs, the Department of Health (DH) announced today.
Receiving vaccines is the most effective means to prevent
seasonal influenza and its complications. It also reduces the risks of
hospitalisation and mortality during the winter influenza season which typically
occurs from January to March or April, the DH said.
“To enhance the stability of vaccine supplies, the
Government has enhanced the procurement procedures this year to introduce
different brands and technology platforms of seasonal influenza vaccines that
are supplied by different vaccine suppliers,” the DH said.
 |
| PINDUTIN PARA SA DETALYE |
“The enhancement aims to diversify supply chain risks,
ensure the reliability and sustainability of vaccine supplies, and enhance the
flexibility of vaccine use in order to increase the vaccination rate,” it added.
To improve the efficiency of logistics management, the
Government will continue to adopt the "first-in, first-out" principle
to flexibly allocate the delivery of the vaccines according to the delivery
schedules of the successful bidders.
All these vaccines are registered with the Pharmacy and
Poisons Board of Hong Kong under the Pharmacy and Poisons Ordinance, and manufacturers
must comply with the Guide to Good Manufacturing Practice (GMP) for Medicinal
Products.
 |
| Basahin ang detalye! |
Two licensed wholesale dealers of pharmaceutical products
were awarded the contracts for the vaccines, all of which are trivalent vaccinesrecommended
by the Scientific Committee on Vaccine Preventable Diseases under the Centre
for Health Protection of the DH.
In addition, the Government launched the Pilot Scheme on
Vaccine Procurement for Family Doctors (Pilot Scheme) in 2025/26. “With the
experience gained from the Pilot Scheme, the Government will continue to
implement the Pilot Scheme in the 2026/27 and strengthen the related
arrangements, including increasing the number of influenza vaccine doses
available for procurement by eligible doctors from 100 000 to 300 000, expanding
the eligibility groups to include doctors who participate in the Vaccination
Subsidy Scheme (VSS) and at least one other Government-subsidised primary
healthcare program and streamlining the overall workflow arrangements and
simplifying the process for consenting to participate in the VSS.
“The above measures will help further enhance the stability
of the vaccine supply in the private market and encourage eligible members of
the public to receive vaccinations,” the DH said.
